The clinical and haemodynamic effects of adrenaline infusion (30 ng kg-' min-') producing plasma adrenaline concentrations in the range seen during acute myocardial infarction and of placebo were investigated in a crossover design in 14 patients with stable coronary heart disease. 
producing plasma adrenaline concentrations in the range seen during acute myocardial infarction and of placebo were investigated in a crossover design in 14 patients with stable coronary heart disease. Adrenaline infusion resulted in electrocardiographic evidence of myocardial ischaemia (.1 mm (0 1 mV) horizontal or downsloping ST segment depression) in 10 patients and angina in four, although the mean (SEM) increase in heart rate was modest (14 (2) beats/ min) and mean coronary vascular resistance fell from 1-56 (0-21) to [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] (0 14) mmHg min ml-' (p < 0-005). New or increasingly frequent or complex ventricular arrhythmias occurred in five patients. Placebo infusion had no effect on the variables measured. Supine bicycle exercise during infusion of the saline placebo was associated with a similar degree of ST segment depression (09 (0 2) mm) as adrenaline infusion at rest (0 9 (0-1) mm) but exercise performed during adrenaline infusion (10 patients) resulted in more pronounced ST segment depression (1 9 (0 3) mm) (p < 0'005) than either intervention alone. Angina occurred in three of 11 patients during control exercise and in six of 10 during the combination of adrenaline infusion and exercise. Such potentially adverse consequences of low dose adrenaline infusion in patients with stable coronary heart disease are consistent with the suggestion that adrenal activation is detrimental during acute myocardial infarction, being both arrhythmogenic and proischaemic.
Acute myocardial infarction is associated with sympathoadrenal activation, and plasma adrenaline concentrations can reach 100 times the baseline upper limit of normal. ' Karlsberg et al found that a high peak adrenaline concentration was associated with increased subsequent mortality,' but it is not clear whether this adverse outcome is due to the high adrenaline concentrations or whether high concentrations are a marker for large infarcts and associated with a poor prognosis for that reason. Nevertheless, the concept that adrenal activation may have significantly adverse consequences after acute myocardial infarction has received little recent attention. The aim of the present study was to investigate whether brief low dose adrenaline infusions, designed to simulate the increases in adrenaline concentration seen during acute myocardial infarction, result in myocardial ischaemia or ventricular arrhythmias in patients with stable symptomatic coronary heart disease.
Patients and methods

PATIENTS
Fourteen male patients, whose clinical details are shown in the table, were studied supine and in the fasting state one hour after diagnostic cardiac catheterisation. All had coronary heart disease (> 50% diameter stenosis of at least one major coronary artery), all had a history of stable typical angina, and six had had a previous myocardial infarction. Thirteen (fig 2) . Figure 3 shows representative electrocardiograms from a patient (case 6).
Exercise produced a greater increase in heart rate than adrenaline infusion (22 (3) beats/min v 14 (2) beats/min, p < 0 01) and the increases in heart rate were similar during the control Figure 3 Electrocardiograms (leads V3, V5, V6) from a patient with coronary heart disease during infusion of saline placebo at rest and while exercising, after recovery from exercise (pre-adrenaline), and during adrenaline infusion at rest and while exercising. The potential adverse effects of adrenaline in the setting of acute myocardial infarction are well recognised: the positive inotropic and chronotropic effects of ft adrenoceptor stimulation may compromise oxygen balance in critically underperfused myocardium, thus increasing infarct size" and possibly the risk of myocardial rupture, and may cause distant myocardial ischaemia in patients with multivessel coronary disease (further compromising pump function and increasing the risk of arrhythmia): the direct arrhythmogenic effects and potential cardiotoxicity of catecholamines are well known.21' Also of potential importance in view of the advent of thrombolytic therapy is the suggestion that catecholamines may be implicated in the genesis of reperfusion arrhythmias. 14 We cannot be certain whether the deleterious effects of adrenaline are catecholamine specific or are due to the increase in heart rate, but it seems unlikely that it is purely a heart rate effect. Adrenaline infusion caused myocardial ischaemia as severe as did supine bicycle exercise, although the heart rate and rate-pressure product were less during adrenaline infusion than during supine bicycle exercise. 
